Medisyn Technologies

About:

Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.

Website: http://www.medisyntech.com

Top Investors: StarTec Investments, MTI Ventures, Andcor Companies, Portage Capital, Sherpa Partners

Description:

Medisyn Technologies, Inc., a biotechnology company, develops pre-qualified proprietary drug compounds. Its Forward Engineering platform is used for producing compounds for breast, renal, prostate, and lung-cancer treatments. The company also analyzes and optimizes existing drugs, and develops new drug candidates for its partners. In addition, it offers testing and analysis services to predict safety and efficacy of compounds. The company serves biotech and pharmaceutical companies. Medisyn Technologies, Inc. was founded in 1999 and is headquartered in Minnetonka, Minnesota.